Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical curcumin for chronic hand eczema
IRCT20240425061563N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of curcumin and mometasone in chronic hand dermatitis (CHE) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Severity of chronic hand eczema. Started May 2024; status: completed.
02
Drugs
curcuminmometasone
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on IRCT20240425061563N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240425061563N1.